Daxor Corporation: Business Overview, Financials & Competitive Analysis
Daxor Corporation scores 7/10 on the AskCyborg Cyborg Score (Strong). Specialized medical device player with unique technology addressing critical unmet clinical need in high-cost patient populations; positioned for accelerating adoption post-FDA clearance. Daxor holds a monopoly-like position in FDA-cleared blood volume measurement with strong clinical validation and expanding adoption across leading hospital systems. Recent FDA clearance for next-generation technology, DoD.
What is Daxor Corporation's industry? Daxor Corporation (daxor.com) operates in Medical Devices - Diagnostics. AskCyborg classifies Daxor Corporation under Medical Devices - Diagnostics in its company registry.
Daxor Corporation is a medical device company that provides blood volume measurement technology, developing and marketing the BVA-100 Blood Volume Analyzer, a diagnostic blood test that provides safe, accurate, object...
Cyborg Score thesis
Specialized medical device player with unique technology addressing critical unmet clinical need in high-cost patient...
Read the full analyst-debate transcript →Get the Latest Daxor Corporation Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeDaxor Corporation Overview
Pro stress-test →Daxor Corporation is a medical device company that provides blood volume measurement technology, developing and marketing the BVA-100 Blood Volume Analyzer, a diagnostic blood test that provides safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for use in a broad range of medical and surgical conditions. The company is tackling healthcare's "multi-billion-dollar silent crisis"—the inability to precisely measure blood volume—which often results in suboptimal care, prolonged hospital stays, and increased readmissions for high-cost conditions like heart failure and ICU care.
Strategic Profile
Pro stress-test →With 50 years of experience and innovation, Daxor manufactures and distributes its patented, FDA-cleared Blood Volume Analysis diagnostic via a rapid, hand-held, lab-based system. The company operates a U.S.-based, 20,000-square-foot state-of-the-art manufacturing facility, positioning the company for accelerated market expansion. In August 2025, Daxor received FDA 510(k) clearance for its patent-pending next-generation rapid, compact, hand-held Blood Volume Analyzer (BVA).
Competitive Landscape
Pro stress-test →Daxor operates in a niche market with minimal direct competitors; its BVA technology is the only FDA-cleared diagnostic test for objective blood volume quantification. Broader competitive context includes clinical decision-support tools from major medical device companies (Edwards Lifesciences, LivaNova) that estimate fluid status indirectly. Daxor's differentiation lies in direct, patient-specific quantification enabling precision fluid management—a capability not replicated by existing alternatives.
Industry Context
Daxor Corporation operates in Medical Devices - Diagnostics.
Key facts
Founded: 1971 · Headquarters: Oak Ridge, Tennessee · Employees: N/A · Revenue: N/A · Market cap: N/A